Skip to main content

Choose your location

Current selection

United States
United States
Asia Regional
New Zealand
United Kingdom


Audience for the document: Share Class: Language of the document:


Share Class: Language of the document:

Change Details

If you need to change your email address please contact us.
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®) and has prepared and presented this report in compliance with the GIPS standards. T. Rowe Price has been independently verified for the twenty four-year period ended June 30, 2020, by KPMG LLP. The verification report is available upon request. A firm that claims compliance with the GIPS standards must establish policies and procedures for complying with all the applicable requirements of the GIPS standards. Verification provides assurance on whether the firm’s policies and procedures related to composite and pooled fund maintenance, as well as the calculation, presentation, and distribution of performance, have been designed in compliance with the GIPS standards and have been implemented on a firm-wide basis. Verification does not provide assurance on the accuracy of any specific performance report.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest


Global Asset Allocation Viewpoints

Our experts share perspective on market themes and regional trends, plus insights into current portfolio positioning.

Market Perspective

As of 30 September 2021

  • Global economic growth outlook remains favorable, albeit past peak levels, balanced by further progress toward global emergence from COVID-19 shutdowns versus fading policy support and supply chain disruptions.
  • Global monetary policy is expected to continue path toward tightening, but central banks on different trajectories, with some, particularly in EM, having already acted in response to higher inflation while others continue to keep policy on hold awaiting stronger evidence of sustained growth.
  • Long-term interest rates could trend higher amid outlook for above trend growth and inflation, but upside may be limited as growth and imbalances driving inflation moderate.
  • Key risks to global markets include elevated inflation, central bank missteps, slowing China growth, supply chain disruption, increased regulatory pressures, higher taxes, and increasing geopolitical concerns.

Portfolio Positioning

As of 30 September 2021

  • We remain modestly underweight equities relative to bonds and cash as valuations look less compelling amid moderating growth and stimulus. Higher rates, rising input costs related to supply chain bottlenecks, and potential tax increases could pose challenges to near-term earnings outlook.
  • Within equities, we continue to favor value-oriented equities globally, U.S. small-caps, and emerging market stocks as we expect cyclically exposed companies to benefit from a supportive global growth profile, coupled with unleashed pent-up demand and inventory rebuilding as supply bottlenecks and COVID concerns abate.
  • Within fixed income, we continue to favor shorter duration and higher yielding sectors through overweights to high yield bonds and floating rate loans given our constructive credit outlook.

Market Themes

As of 30 September 2021

More Predictably, Unpredictable

After a crackdown on internet technology and educational companies last month, risks continue to emerge out of China including the potential fallout in its massive real estate sector following missed debt payments by Evergrande–one of the nation’s largest property developers. The focused suite of regulatory actions out of Beijing are driven by efforts to balance wealth inequality and have had far sweeping impacts on sectors such as technology, education, real estate, and healthcare. At the same time, authorities have started to more aggressively pursue its 5-year plan to reduce carbon emissions by limiting coal supply, resulting in power outages, and shuttering factory activity leading to supply shortages. The degree of recent actions taken by the Chinese government combined with declining growth estimates is causing investors angst. Although unlikely to allow economic growth to fall significantly, China’s actions may force foreign investors and trading partners to reassess the risks of investing in a place that has become more predictably, unpredictable.

Evergrande’s Debt Collapse1

As of 30 September 2021

Line chart illustrating Evergrande's debt collapse by centers on the dollar

Past performance is not a reliable indicator of future performance.
1 Figures are shown in USD.
The specific securities identified and described are for informational purposes only and do not represent recommendations.
Source: Bloomberg Finance L.P.
Source: Financial data and analytics provider FactSet. Copyright 2021 FactSet. All Rights Reserved.

Actions Speak Louder than Words

Inflation is proving to be a bit more persistent and higher than many expected, putting pressure on some central banks around the globe to act. Several emerging market central banks, such as Brazil and Mexico, began raising rates over the summer to fend off higher prices and now, some developed market central banks are similarly looking to act. The Bank of England has signaled higher rates are coming soon as inflation is expected to get close to 4%, double their target. And while the Federal Reserve is planning on tapering asset purchases, it remains committed to its current rate policy, reiterating that elevated inflation levels will be “transitory”. The ECB similarly warned of not overreacting to current inflation levels, keeping current policy in place. Although most central banks believe inflation will prove temporary, prices could remain elevated for an extended period–perhaps too long for them to hold onto their words and not take action.

Global Inflation on the Rise1,2

As of 31 August 2021

Line graph showing inflation percentage by region from 2009-2021

Past performance is not a reliable indicator of future performance.
1 Figures are shown in USD.
2 Inflation is measured by Consumer Price Index.
The specific securities identified and described are for informational purposes only and do not represent recommendations.
Source: Bloomberg Finance L.P.
Source: Financial data and analytics provider FactSet. Copyright 2021 FactSet. All Rights Reserved.

Regional Backdrop

As of 30 September 2021

  Positives Negatives
United States
  • Healthy consumer balance sheets and high savings rate
  • Exceptionally strong earnings growth
  • Infrastructure spending likely to increase
  • Delta variant spread appears to have peaked
  • Elevated stock and bond valuations
  • Elevated corporate and government debt levels
  • Fed accommodation has peaked
  • Fiscal stimulus has peaked
  • Corporate taxes likely to rise
  • Higher exposure to more cyclically oriented sectors that should benefit from economic recovery
  • Monetary policy remains accommodative
  • Fiscal stimulus likely to increase
  • Equity valuations remain attractive relative to the US
  • Limited long-term catalysts for growth
  • Limited scope for European Central Bank to stimulate further
  • Demand from China fading
  • Microchip shortage impacting auto production rebound
Developed Asia/Pacific
  • Cyclical orientation should benefit from economic rebound
  • Strong fiscal and monetary support
  • Improving corporate governance
  • Vaccination rates have improved significantly
  • Improving political outlook
  • Weak economic growth going into crisis, driven by long-term demographic headwind
  • Demand from China fading
  • Limited long-term catalysts for growth
Emerging Markets
  • Equity valuations attractive relative to developed markets
  • Exposure to cyclical areas of economy should benefit from broad global recovery
  • Chinese regulatory actions likely to have peaked
  • Vaccination rates are improving
  • Stimulus from China is fading
  • Accommodation from central banks is fading
  • New coronavirus variants remain a threat

Asset Allocation Committee Positioning

As of 30 September 2021

Chart characterizing various equities and bonds by underweight, neutral or overweight.

1For pairwise decisions in style & market capitalization, positioning within boxes represent positioning in the first mentioned asset class relative to the second asset class.
The asset classes across the equity and fixed income markets shown are represented in our Multi-Asset portfolios. Certain style & market capitalization asset classes are represented as pairwise decisions as part of our tactical asset allocation framework. For a representation of how the overweight and underweight tactical decisions are implemented across our Target Allocation franchise, please see page 4.

Portfolio Implementation

As of 30 September 2021

Chart demonstrating tactical allocation weights of various equities

1 U.S. small-cap includes both small- and mid-cap allocations.
Source: T. Rowe Price. Unless otherwise stated, all market data are sourced from FactSet. Copyright 2021 FactSet. All Rights Reserved.
These are subject to change without further notice. Figures may not total due to rounding.
Neutral equity portfolio weights representative of a U.S.-biased portfolio with a 70% U.S. and 30% international allocation; includes allocation to real assets equities. Core fixed income allocation representative of U.S.-biased portfolio with 55% allocation to U.S. investment grade.
Source: MSCI. MSCI and its affiliates and third party sources and providers (collectively, “MSCI”) makes no express or implied warranties or representations and shall have noliability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities orfinancial products. This report is not approved, reviewed, or produced by MSCI. Historical MSCI data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.
“Bloomberg®” and Bloomberg Global Aggregate Index are service marks of Bloomberg Finance L.P. and its affiliates, including Bloomberg Index Services Limited(“BISL”), the administrator of the index (collectively, “Bloomberg”) and have been licensed for use for certain purposes by T. Rowe Price. Bloomberg is not affiliated with T. Rowe Price, and Bloomberg does not approve, endorse, review, or recommend Global Asset Allocation Viewpoints. Bloomberg does not guarantee the timeliness, accurateness, or completeness of any data or information relating to Global Asset Allocation Viewpoints.


This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, and prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.  

It is not intended for distribution to retail investors in any jurisdiction.

USA—Issued in the USA by T. Rowe Price Associates, Inc., 100 East Pratt Street, Baltimore, MD, 21202, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.

© 2021 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the bighorn sheep design are, collectively and/or apart, trademarks or registered trademarks of T. Rowe Price Group, Inc.

Previous Article

October 2021 / GLOBAL EQUITIES

Investing in Health Care’s Technological Transformation
Next Article

October 2021 / U.S. FIXED INCOME

High Valuations Balance Healthy Credit in Global High Yield

You are now leaving the T. Rowe Price website

T. Rowe Price is not responsible for the content of third party websites, including any performance data contained within them. Past performance is not a reliable indicator of future performance.